These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 12612977

  • 21. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
    El-Melegy NT, Mohamed NA, Sayed MM.
    Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747
    [Abstract] [Full Text] [Related]

  • 22. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
    Tain YL, Liu CA, Yang KD.
    Pediatr Nephrol; 2002 Nov; 17(11):926-32. PubMed ID: 12432436
    [Abstract] [Full Text] [Related]

  • 23. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome.
    Kabuki N, Okugawa T, Hayakawa H, Tomizawa S, Kasahara T, Uchiyama M.
    Pediatr Nephrol; 1998 Aug; 12(6):467-70. PubMed ID: 9745870
    [Abstract] [Full Text] [Related]

  • 24. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 25. Predictors of relapse in steroid-sensitive nephrotic syndrome.
    Noer MS.
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1313-20. PubMed ID: 16438164
    [Abstract] [Full Text] [Related]

  • 26. Long-term outcome of the difficult nephrotic syndrome in children.
    Al Salloum AA, Muthanna A, Bassrawi R, Al Shehab AA, Al Ibrahim A, Islam MZ, Al Hasan K.
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):965-72. PubMed ID: 22982908
    [Abstract] [Full Text] [Related]

  • 27. The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study.
    Aydin M, Franke I, Kurylowicz L, Ganschow R, Lentze M, Born M, Hagemann R.
    Clin Exp Nephrol; 2019 May; 23(5):676-688. PubMed ID: 30721392
    [Abstract] [Full Text] [Related]

  • 28. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
    Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K.
    Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
    [Abstract] [Full Text] [Related]

  • 30. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
    Norero C, Delucchi A, Lagos E, Rosati P.
    Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
    [Abstract] [Full Text] [Related]

  • 31. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome.
    Kemper MJ, Altrogge H, Ganschow R, Müller-Wiefel DE.
    Pediatr Nephrol; 2002 Jun; 17(6):413-7. PubMed ID: 12107805
    [Abstract] [Full Text] [Related]

  • 32. Apolipoprotein E polymorphism in childhood nephrotic syndrome.
    Attila G, Noyan A, Karabay Bayazit A, Acartürk E, Anarat A.
    Pediatr Nephrol; 2002 May; 17(5):359-62. PubMed ID: 12042894
    [Abstract] [Full Text] [Related]

  • 33. [Current aspects of transformation of morphological changes in children with nephrotic syndrome depending on the treatment regimen].
    Sharipov AM, Khamzaeva KA.
    Urologiia; 2007 May; (2):68-71. PubMed ID: 17580388
    [Abstract] [Full Text] [Related]

  • 34. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 35. Patterns of Childhood Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome in Saudi Children.
    Alharthi AA.
    Clin Pediatr (Phila); 2017 Feb; 56(2):177-183. PubMed ID: 27130200
    [Abstract] [Full Text] [Related]

  • 36. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY, Funk M, Mengel M, Doehring E, Ehrich JH.
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [Abstract] [Full Text] [Related]

  • 37. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [Abstract] [Full Text] [Related]

  • 38. Circannual variation in the onset and relapse of steroid-sensitive nephrotic syndrome.
    Toyabe S, Nakamizo M, Uchiyama M, Akazawa K.
    Pediatr Nephrol; 2005 Apr; 20(4):470-3. PubMed ID: 15719252
    [Abstract] [Full Text] [Related]

  • 39. Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency.
    Fan A, Jiang X, Mo Y, Tan H, Jiang M, Li J.
    Pediatr Nephrol; 2016 Jan; 31(1):83-8. PubMed ID: 26341250
    [Abstract] [Full Text] [Related]

  • 40. IL-18 is correlated with type-2 immune response in children with steroid sensitive nephrotic syndrome.
    Printza N, Papachristou F, Tzimouli V, Taparkou A, Kanakoudi-Tsakalidou F.
    Cytokine; 2008 Nov; 44(2):262-8. PubMed ID: 18819819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.